Analyst firms · Oppenheimer · PMVP

Oppenheimer PMVP price target and rating history

PMV Pharmaceuticals Inc. (PMVP) · Health Care

Oppenheimer rates PMV Pharmaceuticals Inc. (PMVP) Outperform with a $6 price target, as of its latest action on Nov 8, 2024. It has published 4 rating actions on PMVP since August 2021, including 3 upgrades and 0 downgrades.

Current rating
Outperform
Price target
$6
Median target, all firms
Too few
Actions on PMVP
4

Oppenheimer price target on PMVP

$30$18$62023202420252026
Oppenheimer price target on PMVP, each point a stated target, March 2022 to November 2024.

Every Oppenheimer rating on PMVP

Questions about Oppenheimer and PMVP

What is Oppenheimer's price target for PMVP?
Oppenheimer's latest stated price target for PMV Pharmaceuticals Inc. (PMVP) is $6, from its action on Nov 8, 2024.
What is Oppenheimer's rating on PMVP?
Oppenheimer rates PMVP Outperform, a bullish rating, as of Nov 8, 2024.
When did Oppenheimer last change its view on PMVP?
On Nov 8, 2024, Oppenheimer upgrades to Outperform from Perform, price target $6.

All Oppenheimer ratingsPMVP news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.